Stryker Shares Trade 13% Below Fair Value with 20.1 Forward P/E
SYK•Stryker trades at a 13% discount to fair value with a forward P/E of 20.1 compared with its 10-year average of 25.6. Consensus forecasts adjusted diluted EPS to compound at 11.2% annually through 2028, underpinning high single-digit dividend growth.
1. Valuation Metrics
Stryker's shares trade at a 13% discount to calculated fair value based on a forward price-to-earnings ratio of 20.1, compared with its 10-year average of 25.6. This valuation gap suggests potential upside as market multiples normalize.
2. Growth Outlook and Dividend
Consensus forecasts adjusted diluted EPS to compound at 11.2% annually through fiscal 2028, driven by robust medtech industry expansion and the company's innovation pipeline. This earnings growth underpins management's commitment to high single-digit dividend increases over the same period.
